IQVIA (IQV) stock, ICON (ICLR) stock, and Fortrea (FTRE) stock were downgraded at Barclays, citing impact from potential pharma tariffs. Read more here.

With the stock near all-time low valuations, we are holding." A laboratory setting with a team of scientists working on a clinical trial. ICON Public Limited Company (NASDAQ:ICLR) is not on our ...

In a report released today, Luke Sergott from Barclays downgraded Icon (ICLR – Research Report) to a Hold, with a price target of $165.00. The ...

ICON Health and InformationTechnology Fd earns ... This means the fund avoids holding firms that are consistently profitable, growing, and have solid balance sheets. Lacking this ballast, the ...